The atypical antipsychotic, clozapine has some selectivity for dopamine D4 receptors and is a silent antagonist at these receptors. NGD 94-1 (2-phenyl-4(5)-[4-(2-pyrimidinyl)-piperazin-1-yl-methyl]-imidazole ) is a highly selective dopamine D4 receptor ligand recently introduced as a putative antipsychotic mimicking the dopamine D4 receptor antagonist effects of clozapine. We show that NGD 94-1 is not silent. It behaved as an agonist in human embryonic kidney 293 cells expressing human recombinant dopamine D4.4 receptors. This questions the clinical use of NGD 94-1.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0014-2999(99)00254-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Dopamine D₄ Receptor Antagonists for the Treatment of Cocaine Use Disorders.
CNS Neurol Disord Drug Targets
March 2016
Preclinical Pharmacology Laboratory, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA.
Article Synopsis
- Research is ongoing to find effective medications for cocaine use disorders, focusing on dopamine receptor antagonists, particularly D4 receptors.
- The study highlights findings from nonhuman primates where certain D4-selective compounds showed potential in reducing cocaine self-administration without affecting food-related behaviors.
- These promising results indicate that D4 receptor antagonists warrant further investigation as possible treatments for cocaine addiction.
SPECT imaging with the D(4) receptor antagonist L-750,667 in nonhuman primate brain.
Nucl Med Biol
August 2000
Department of Psychiatry, Yale University School of Medicine & VA Connecticut Healthcare System, West Haven, Connecticut, USA.
The suitability of an (123)I-labeled form of the putative D(4) receptor ligand L750,667 as a radiotracer for single photon emission computed tomography imaging was assessed in nonhuman primates. [(123)I]L750,667, labeled by iododestannylation, was administered to baboons in bolus and bolus plus constant infusion paradigms and imaged for 6 h. Total [(123)I]L750,667 brain uptake peaked (2.
View Article and Find Full Text PDFCloning, expression, functional coupling and pharmacological characterization of the rat dopamine D4 receptor.
Naunyn Schmiedebergs Arch Pharmacol
May 2000
Nervous System Research, Novartis Pharma AG, Basel, Switzerland.
It has been difficult to observe functional coupling of the D4 receptor to second messenger systems and a robust functional assay system for this receptor is still lacking. In the present study, the rat dopamine D4 receptor was cloned from rat retina. Sequence comparison revealed identity with the published sequence of Ashgari and co-workers, including the two amino acid insertions (V-Q) at position 92 which are not present in the published sequence of O'Malley and coworkers.
View Article and Find Full Text PDFNGD 94-1 as an agonist at human recombinant dopamine D4.4 receptors expressed in HEK293 cells.
Eur J Pharmacol
May 1999
Nervous System Therapeutic Area, Novartis Pharma Research, Novartis Pharma, Basel, Switzerland.
The atypical antipsychotic, clozapine has some selectivity for dopamine D4 receptors and is a silent antagonist at these receptors. NGD 94-1 (2-phenyl-4(5)-[4-(2-pyrimidinyl)-piperazin-1-yl-methyl]-imidazole ) is a highly selective dopamine D4 receptor ligand recently introduced as a putative antipsychotic mimicking the dopamine D4 receptor antagonist effects of clozapine. We show that NGD 94-1 is not silent.
View Article and Find Full Text PDFDopamine D4 receptor antagonist reversal of subchronic phencyclidine-induced object retrieval/detour deficits in monkeys.
Psychopharmacology (Berl)
February 1999
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510, USA.
D4 dopamine receptors (DRs) are enriched in the primate prefrontal cortex, a brain region implicated in cognitive processes, and mesoprefrontal dopaminergic systems appear to be involved in modulating some cognitive functions of the prefrontal cortex. Despite anatomical localization of D4 DRs within the frontal cortex, the role of these receptors, specifically, in the regulation of cognition or behavior in primates is unknown. In these studies, we sought to learn whether specific antagonism of D4 DRs would affect performance of a task dependent on the frontostriatal system.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!